Celltrion
068270.KS
#739
Rank
โ‚ฌ25.88 B
Marketcap
120,29ย โ‚ฌ
Share price
-0.55%
Change (1 day)
-4.66%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Market capitalization of Celltrion (068270.KS)

Market cap: โ‚ฌ25.88 Billion

As of January 2025 Celltrion has a market cap of โ‚ฌ25.88 Billion. This makes Celltrion the world's 739th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celltrion from 2007 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ25.88 B2.07%
2024โ‚ฌ25.35 B-16.27%
2023โ‚ฌ30.28 B79.19%
2022โ‚ฌ16.90 B-17.45%
2021โ‚ฌ20.47 B-44.15%
2020โ‚ฌ36.65 B106.25%
2019โ‚ฌ17.77 B-18.13%
2018โ‚ฌ21.70 B1.2%
2017โ‚ฌ21.45 B107.57%
2016โ‚ฌ10.33 B39.82%
2015โ‚ฌ7.39 B148.23%
2014โ‚ฌ2.97 B15.29%
2013โ‚ฌ2.58 B-21.37%
2012โ‚ฌ3.28 B16.83%
2011โ‚ฌ2.81 B8.49%
2010โ‚ฌ2.59 B181.57%
2009โ‚ฌ0.92 B59.55%
2008โ‚ฌ0.57 B4409.11%
2007โ‚ฌ12.79 M

End of Day market cap according to different sources

On Jan 20th, 2025 the market cap of Celltrion was reported to be:

โ‚ฌ26.08 Billion
by Yahoo Finance info icon info icon
โ‚ฌ26.08 Billion
by CompaniesMarketCap info icon info icon